Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 8.79, with a low estimate of 7.00 and a high estimate of 14.5. The average target predicts an increase of 30.51% from the current stock price of 6.74.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$7.00	$8.79	$8.00	$14.5
Change	+3.93%	+30.51%	+18.78%	+115.29%

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	6	7	7	7	7	7
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $9.5 → $8	Hold	Maintains	$9.5 → $8	+18.78%	Apr 11, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $10 → $9.5	Hold	Maintains	$10 → $9.5	+41.05%	Mar 13, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $8.4 → $10	Hold	Maintains	$8.4 → $10	+48.48%	Mar 3, 2025
Ben Haynor Lake Street	Lake Street	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+115.29%	Dec 31, 2024
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $7 → $8.4	Hold	Maintains	$7 → $8.4	+24.72%	Dec 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

232.08M

from 209.36M

10.85%

from 209.36M

Revenue Next Year

255.44M

from 232.08M

10.07%

from 232.08M

EPS This Year

-0.85

from -0.90

EPS Next Year

-0.71

from -0.85

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	57.37M	94.42M	141.84M	187.12M	209.36M	232.08M	255.44M	278.34M
Revenue Growth	45.54%	64.59%	50.22%	31.92%	11.89%	10.85%	10.07%	8.96%
EPS	-0.12	-0.43	-0.77	-0.81	-0.90	-0.85	-0.71	-0.58
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	240.9M	269.9M	296.8M
Avg	232.1M	255.4M	278.3M
Low	222.1M	240.2M	258.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	15.1%	16.3%	16.2%
Avg	10.9%	10.1%	9.0%
Low	6.1%	3.5%	1.3%

EPS Forecast

EPS	2025	2026	2027
High	-0.82	-0.66	-0.16
Avg	-0.85	-0.71	-0.58
Low	-0.93	-0.79	-0.79

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.